We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M Turnover 65.26%
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$53M
Cap. Flow
-$59.9M
Cap. Flow %
-23.49%
Top 10 Hldgs %
4.95%
Holding
921
New
282
Increased
115
Reduced
203
Closed
319
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Healthcare 21.14%
2 Industrials 16.14%
3 Consumer Discretionary 14.21%
4 Technology 13.68%
5 Financials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ARNA
826
DELISTED
Arena Pharmaceuticals
ARNA
– –
-34,009
Closed -$497K –
CSLT
827
DELISTED
Castlight Health
CSLT
– –
-25,493
Closed -$93K –
MRLN icon
828
DELISTED
Marlin Business Services
MRLN
– –
-8,155
Closed -$210K –
LDL
829
DELISTED
Lydall
LDL
– –
-4,147
Closed -$222K –
ALXN
830
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-3,881
Closed -$471K –
GLOG
831
DELISTED
GasLog
GLOG
– –
-83,591
Closed -$1.28M –
CLGX
832
DELISTED
CoreLogic
CLGX
– –
-11,832
Closed -$482K –
PTVCB
833
DELISTED
Protective Insurance Class B
PTVCB
– –
-11,429
Closed -$279K –
EGOV
834
DELISTED
NIC Inc
EGOV
– –
-24,609
Closed -$497K –
ANH
835
DELISTED
Anworth Mortgage Asset
ANH
– –
-22,490
Closed -$125K –
RLH
836
DELISTED
Red Lions Hotel
RLH
– –
-22,243
Closed -$157K –
OXFD
837
DELISTED
Oxford Immunotec Global
OXFD
– –
-14,125
Closed -$219K –
PRGX
838
DELISTED
PRGX Global
PRGX
– –
-16,275
Closed -$104K –
BMCH
839
DELISTED
BMC Stock Holdings
BMCH
– –
-9,314
Closed -$210K –
AMAG
840
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-55,361
Closed -$1.25M –
INWK
841
DELISTED
InnerWorkings
INWK
– –
-36,106
Closed -$360K –
PTLA
842
DELISTED
Portola Pharmaceuticals
PTLA
– –
-22,599
Closed -$886K –
TUES
843
DELISTED
Tuesday Morning
TUES
– –
-13,788
Closed -$52K –
LBY
844
DELISTED
Libbey
LBY
– –
-27,986
Closed -$408K –
CORV
845
DELISTED
Correvio Pharma
CORV
– –
-14,620
Closed -$44K –
TLRA
846
DELISTED
Telaria
TLRA
– –
-26,900
Closed -$54K –
INF
847
DELISTED
Brookfield Global Listed Infrastructure Income Fund
INF
– –
-36,224
Closed -$478K –
PKD
848
DELISTED
Parker Drilling
PKD
– –
-1,687
Closed -$44K –
GNMX icon
849
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-49,461
Closed -$92K –
AVP
850
DELISTED
Avon Products
AVP
– –
-275,069
Closed -$1.21M –

Similar funds

TFS Capital's Q2 2017 Portfolio in Review

As of Q2 2017, TFS Capital held 921 positions worth $255M, down 17% from $308M the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.

TFS Capital withdrew a net $59.9M in Q2 2017, closing 319 positions and reducing 203 holdings. Its most notable exit was ePlus, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in MYR Group worth $1.06M.

  • TFS Capital's largest Q2 2017 buy was MYR Group: 34,070 shares worth $1.06M.
  • TFS Capital added most to ModivCare in Q2 2017, an estimated $871K increase.
  • TFS Capital's biggest Q2 2017 reduction was Insight Enterprises, cutting an estimated $1.31M.
  • TFS Capital fully exited ePlus in Q2 2017, selling an estimated $1.71M.
  • TFS Capital's ten largest holdings make up 4.9% of its $255M portfolio in Q2 2017.
  • TFS Capital opened 282 new positions and closed 319 in Q2 2017.
  • TFS Capital's portfolio value fell 17% quarter-over-quarter to $255M.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.